The Icahn School of Medicine at Mount Sinai in New York City has become the first in the nation to incorporate AI into its doctor training program, granting access to OpenAI's ChatGPT Edu to all of its M.D. and graduate students.
A CBS News analysis of IRS data found some nonprofit hospitals in Philadelphia and across the country attempt to collect hundreds of millions of dollars a year from low-income patients. All the big hospitals in the Philadelphia area are nonprofit, and that means they receive federal, state and local tax breaks. In exchange, nonprofit hospitals are required to provide free or discounted care to those who can't afford to pay. However, our investigation found the law is vague, and some patients may be falling through the cracks.
President Trump's bombshell executive order aimed at lowering U.S. drug prices is a step toward a worst-case scenario for the pharmaceutical industry. Some critics say the industry could have done more to avoid it, even though Trump's policies are causing turmoil in almost every sector of the economy. Trump's announcement could be the start of enormous global disruption for the pharmaceutical industry — or it's the least-bad version of what was on the table, depending on who you ask.
CMS said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by early February next year. For the first time, the list would include drugs payable under Medicare Part B - which covers medicines administered in a doctor's office or hospital - in addition to prescription drugs covered under Medicare Part D, CMS said.
People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications. Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds over 72 weeks, while those who took semaglutide, or Wegovy, lost about 33 pounds. That's according to the study funded by Lilly, which was published this week in NEJM.
HHS says a recent Ascension Healthcare breach affected 437,329 patients. Ascension did not disclose the number of patients affected when it first reported the April 28 breach a couple of weeks ago. While it's a much smaller number than the 5.6 million people affected by the May 2024 breach involving ransomware group Black Basta, security pros still considered it a significant incident.